Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Net Cash Flow (2019 - 2025)

Bioadaptives' Net Cash Flow history spans 7 years, with the latest figure at $99172.0 for Q4 2025.

  • Quarterly results put Net Cash Flow at $99172.0 for Q4 2025, up 5.98% from a year ago — trailing twelve months through Dec 2025 was -$261025.0 (down 685.28% YoY), and the annual figure for FY2025 was $20975.0, down 72.65%.
  • Net Cash Flow for Q4 2025 was $99172.0 at Bioadaptives, up from -$151309.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $111951.0 in Q3 2023 to a low of -$151309.0 in Q3 2025.
  • The 5-year median for Net Cash Flow is -$7256.5 (2021), against an average of -$8011.9.
  • The sharpest move saw Net Cash Flow surged 3057.68% in 2021, then crashed 1654.5% in 2023.
  • Year by year, Net Cash Flow stood at $16597.0 in 2021, then tumbled by 64.61% to $5873.0 in 2022, then crashed by 1654.5% to -$91296.0 in 2023, then soared by 202.5% to $93577.0 in 2024, then rose by 5.98% to $99172.0 in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $99172.0, -$151309.0, and -$110982.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.